University Hospital Basel
Basel, Canton of Basel-City, 4031, Switzerland
NCT Number: NCT03455036
Intense itch on the legs sometimes associated with redness can be adverse effects of whole body vibration (WBV) according to own observations and numerous posts in non-professional online-blogs. To the investigators' knowledge, the appearance of itch and/or a rash during WBV exercise has not yet been described.
The research objectives are:
1. To determine the effect of WBV on itch rating and its unpleasantness and on skin changes. 2. To determine the effect of WBV on immunoglobulin E (IgE) and serum tryptase
Looking for future studies?
Notify Me18 year–35 year
Female
Interventional
Not applicable
Basel, Canton of Basel-City, 4031, Switzerland
Objectives Intense itch on the legs sometimes associated with redness can be adverse effects of WBV according to the investigators observations and numerous posts in non-professional online-blogs. To the investigators knowledge, the appearance of itch and/or a rash during WBV exercise has not yet been described.
The objectives of this study are:
Hypothesis The working hypothesis is that repeated WBV leads to an increase of itching and erythema. Further investigators hypothesize that repeated WBV does not lead to an increase in serum tryptase.
Inclusion and exclusion criteria will be evaluated. Subjects will be instructed to not shave their legs one week before the intervention day and to shave only the left leg from the ankle to the knee on the day prior to the intervention day.
On the intervention day, subjects will be informed in detail about the study protocol and written informed consent will be collected. If a pregnancy cannot be excluded (days from last menstruation) subjects are instructed to do a pregnancy test. Then, a blood sample will be taken. Subsequently, subjects will be instructed to stand on the vibration plate (Galileo 900) in a slightly crouched position with their hands loosely resting on the rail. Subjects will complete ten 1-minute WBV repetitions interspaced by 1-minute breaks in seated position. During each break, subjects will rate the itch intensity, and skin changes will be captured. Sixty minutes after the last WBV repetition, another blood sample will be taken. Subjects will rest until itch and erythema return to baseline. During resting phase subjects will fill in the Eppendorf itch questionnaire and the Erlanger atopy score.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
10 x 1 min whole body vibration exposure
Time frame: 0 months
0 to 10 numerical rating scale (NRS) (best score: 0 - no itch; worst score: 10)
Time frame: 0 months
Erlanger atopy score (best score: 0 - no atopy; worst score: 100)
Time frame: 0 months
measured using Eppendorf itch questionnaire
Time frame: 0 months
0 to 10 numerical rating scale (NRS) (best score: 0 - no unpleasantness; worst score: 10)
Time frame: 0 months
assessed using a infrared thermal camera
Time frame: 0 months
assessed using an erythema meter
Time frame: 0 months
Serum
Time frame: 0 months
serum
University Hospital, Basel, Switzerland
Other
Acronym: VIBRA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01870414
Individual Adjustment, Itch; Athlete
Ribeirão Preto, São Paulo, Brazil
View Trial DetailsNCT01081574
Airway Obstruction, Allergic Rhinoconjunctivitis
Parkville, Victoria, Australia
View Trial DetailsNCT00796211
Erythema, Pathological Conditions, Signs and Symptoms
Münster, Germany
View Trial DetailsNCT07014007
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Quatre Bornes, Mauritius
View Trial Details